Stalmack Kathryn 4
4 · BioScrip, Inc. · Filed Apr 18, 2019
Insider Transaction Report
Form 4
BioScrip, Inc.BIOS
Stalmack Kathryn
General Counsel
Transactions
- Disposition to Issuer
Common Stock, $.0001 Par Value
2019-04-17$1.82/sh−3,378$6,148→ 77,975 total - Exercise/Conversion
Common Stock, $.0001 Par Value
2019-04-17+9,843→ 81,353 total - Exercise/Conversion
Restricted Stock Unit
2019-04-17−9,843→ 19,684 total→ Common Stock, $.0001 Par Value (9,843 underlying)
Footnotes (4)
- [F1]One third (9,843 Restricted Stock Unites (RSUs)) vested on the first anniversary of the original grant date (April 11, 2018); however, as provided in the grant agreement, the Company deferred settlement of the RSUs until April 17, 2019.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of Common Stock.
- [F3]This transaction represents shares withheld by the Company for tax withholding on Ms. Stalmack's settlement of the 9,843 RSUs that vested on April 11, 2019.
- [F4]The remaining 19,684 RSUs vest in two equal installments commencing on the second and third anniversaries of the date of grant (4/11/2018).